gday,
wanted to start a discussion on what to expect and how to interpret the upcoming results. Given that we are now in april they can drop at any time.
As i understand it genocea currently have the results we need to compare against as their final phase 2 results are the best out there. Below is a table of their results.
![]()
as i don't have a medical background i'm not entirely sure exactly which figures to compare against (hopefully some with appropriate education and background could help here)
Comparing the interim AHZ results against this table, i believe we compare to dose 3 column (as this is what was reported in the interim results) link to announcement here
http://www.asx.com.au/asxpdf/20161019/pdf/43c35546jbmprc.pdf
my humble interpretation:
admedus vs genocea at interim stage
shedding: 58 v 41%
lesions: 81 v 62%
so i believe these next round of results are going to be compared to the last column of genoceas results being the 12 months column.
that is my interpretation, probably wrong but a starting point for us.
those in the know please continue on from here.
very excited for this month and good luck
- Forums
- ASX - By Stock
- AVR
- hsv2 final results
hsv2 final results
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.20 |
Change
0.050(0.33%) |
Mkt cap ! $292.1M |
Open | High | Low | Value | Volume |
$15.35 | $15.35 | $15.00 | $20.85K | 1.367K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 132 | $15.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.30 | 290 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 148 | 15.200 |
1 | 50 | 15.040 |
1 | 630 | 15.000 |
2 | 1651 | 14.950 |
1 | 300 | 14.900 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 4 | 1 |
15.300 | 288 | 1 |
15.570 | 35 | 1 |
15.700 | 277 | 1 |
15.880 | 250 | 1 |
Last trade - 10.50am 31/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online